IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis.
about
IDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma Patients.Impact of glycemia on survival of glioblastoma patients treated with radiation and temozolomide.Radiological features combined with IDH1 status for predicting the survival outcome of glioblastoma patients.Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma.The challenges associated with molecular targeted therapies for glioblastoma.Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With GlioblastomasSurvival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis.Association of Telomerase Reverse Transcriptase Promoter Mutations with the Prognosis of Glioma Patients: a Meta-Analysis.Prognostic role of IDH mutations in gliomas: a meta-analysis of 55 observational studies.Glioblastoma Treatment in the Elderly.Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection.Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.The effect of IDH1 mutation on the structural connectome in malignant astrocytoma.Non-invasive tumor genotyping using radiogenomic biomarkers, a systematic review and oncology-wide pathway analysis.
P2860
Q35686908-664FBE49-155D-40CA-801E-FDB857B74C99Q35837629-70E33030-1842-41A5-B99E-4EACF2D76DB8Q36705913-62485B76-46AF-4626-87F6-4E46CE62067DQ37688213-50E883F9-0639-4D7E-BE62-E4DA0F7CF2E0Q38743460-017788F1-2A93-4994-A160-1BFF22E9E06FQ38843549-81A87C0D-9F74-4DDE-B45D-BDD7E754BAF2Q39046974-763B2196-216E-4F40-A128-C4CE8D89FF5CQ40560920-CCA63438-733E-4AE4-A72D-C2D9FF8A610FQ41536288-FC06E8A6-6481-4BA4-9183-8FD6D6CDA2E0Q47107733-5DF2EA13-E0BB-460D-9151-96831D54A48BQ47146223-224F1F47-8024-4FFC-BADD-B1D6B9D875C1Q48299999-BBA0AD83-68CB-4F48-B394-0AFE2B3D56ECQ48428684-2132DD60-5268-44D0-89EA-2A40AEDFC268Q54948216-E7D1B826-35E7-4E55-9A43-F9E87A49F516
P2860
IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
IDH1 mutation is associated wi ...... glioblastoma: a meta-analysis.
@en
IDH1 mutation is associated wi ...... glioblastoma: a meta-analysis.
@nl
type
label
IDH1 mutation is associated wi ...... glioblastoma: a meta-analysis.
@en
IDH1 mutation is associated wi ...... glioblastoma: a meta-analysis.
@nl
prefLabel
IDH1 mutation is associated wi ...... glioblastoma: a meta-analysis.
@en
IDH1 mutation is associated wi ...... glioblastoma: a meta-analysis.
@nl
P2093
P2860
P1433
P1476
IDH1 mutation is associated wi ...... glioblastoma: a meta-analysis.
@en
P2093
Hong-Bin Cheng
Ru-You Zhang
Shao-Shan Hu
P2860
P2888
P304
P356
10.1007/S13277-013-0934-5
P577
2013-08-01T00:00:00Z